Mirati Therapeutics Inc.
MRTX | NASDAQ
$58.70
-$0.10 (-0.17%)
At close: Jan 22, 2024, 04:00 PM ET
Market Data
Market Cap $4.12B
Enterprise Value $3.19B
Beta 0.77
Average Volume N/A
Shares Outstanding (Diluted) 64.99M
Shares Change YoY 15.61%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 3.5%
1Y CAGR (ann.) 28.6%
5Y CAGR (ann.) -2.0%
All-Time CAGR 22.3%
Valuation
PE Ratio -4.87
Forward PE N/A
PEG Ratio -0.39
Forward PEG -0.39
PS Ratio 107.82
Forward PS N/A
PB Ratio 4.35
P/FCF Ratio -6.91
P/Adj. FCF Ratio -5.22
P/OCF Ratio -5.78
EV/Sales 83.57
EV/EBIT -4.22
EV/EBITDA -4.20
EV/FCF -5.36
Earnings Yield -20.6%
FCF Yield -14.5%
Adj. FCF Yield -19.1%
Financial Health
Net Cash $968.41M
Total Debt $50.22M
Cash & Short-Term Investments $976.43M
Total Assets $1.13B
Current Ratio 6.96
Quick Ratio 6.94
Debt / Equity Ratio 0.05
Debt / EBITDA -0.07
Debt / FCF -0.08
OCF / Debt -11.83
Interest Coverage 0.00
Altman Z-Score 8.63
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 95.2%
Operating Profit Margin -2002.8%
EBITDA Margin -6084.4%
Net Profit Margin -5957.4%
FCF Margin -1560.4%
Adj. FCF Margin -2064.5%
SBC / Revenue 1497.2%
SBC Impact (per share) -32.3%
Returns
Return on Assets -61.6%
Return on Equity -61.9%
Return on Invested Capital -72.3%
Return on Capital Employed -72.8%
Return on Tangible Assets -62.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 46.2%
Revenue CAGR 5Y 32.2%
Revenue CAGR 10Y 33.1%
EPS CAGR 3Y -10.8%
EPS CAGR 5Y -21.7%
EPS CAGR 10Y -17.8%
FCF CAGR 3Y -25.7%
FCF CAGR 5Y -34.0%
FCF CAGR 10Y -30.3%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 31
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Feb 26, 2024
EPS Estimate (next Q) -$2.66
EPS Growth Est (next Q) -24.2%
Revenue Est (next Q) $23.01M
Revenue Growth Est (next Q) 2363.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $102.10
Price Target Upside 73.9%
Cash Flow
Operating Cash Flow $-594.1M
Free Cash Flow $-595.93M
Adj. Free Cash Flow $-788.45M
FCF Per Share -$10.23
OCF Per Share -$10.15
OCF/S Ratio -4588.1%
Income Statement
Revenue $38.19M
Gross Profit $-108.29M
Operating Income $-764.87M
EBITDA $-760.68M
Net Income $-725.88M
EPS (Diluted) -$12.06
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove MRTX